Pretreatment with standard‐dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).

Autor: Essilini, Anaïs1,2, Comont, Thibault3, Germain, Johanne1, Brun, Natacha4, Dingremont, Claire5, Castel, Brice6, Arista, Sophie7, Madaule, Serge8, Sailler, Laurent1,2,9, Lapeyre‐Mestre, Maryse1,2,10, Beyne‐Rauzy, Odile3, Godeau, Bertrand11, Adoue, Daniel3, Moulis, Guillaume1,2,9 moulis.g@chu-toulouse.fr, the CARMEN investigators group
Zdroj: European Journal of Haematology. May2018, Vol. 100 Issue 5, p412-418. 7p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje